The study showed diabetic patients taking GLP-1 drugs, such as semaglutide and tirzepatide, faced significantly lower risks of 30-day readmission, wound re-opening and hematoma after surgery, compared ...

The rise in medication usage for weight loss unlocks opportunities for innovation in health-focused products and services, the Circana report found.

Donald Trump threw out yet another threat of tariffs when he floated hitting Denmark with the economic punishment if it did not consider his proposal for the U.S. to buy Greenland.

LifeVantage shares soared Wednesday after the company said its financial outlook for 2025 is brighter than previously expected. The health and nutrition company's stock rose 30% to $21.40 in morning ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are two of the most valuable healthcare stocks in the world, largely due ...

New findings provide industry leaders with actionable insights to develop personalized products and services that support ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

U.S.-listed shares of Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) are up 3.5% premarket, following a bull note ...

SHOPPING: Ready to finally crush those weight loss goals in the new year? All you need is this supplement that boosts GLP-1 ...

As India steps into 2025, breakthrough weight-loss drugs, economic shifts, and global trends shape the road to a Viksit ...

The past year was a great one for the stock market as a whole, but there were plenty of companies that didn't do well in 2024 ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...